Sialic acid concentration in serum and tissue of endometrial cancer patients

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 76, Issue 2, 1998, Pages 211-215

  Paszkowska, Alicja ^a   Berbeć, Henryk ^a   Semczuk, Andrzej ^b   Cybulski, Marek ^a  

^a Poland   (Poland)

^b Sch Med   (Poland)

Author keywords

Endometrial cancer; Serum sialic acid; Tissue sialic acid; Tumor tissue

Indexed keywords

SIALIC ACID;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0032007832     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(97)00176-0     Document Type: Article

References (32)

1. Narayanan S. Sialic acid as a tumor marker. Ann Clin Lab Sci. 24:1994;376-384.
2. Patel P.S., Adhvaryu S.G., Balar D.B., Parikh B.J., Shah P.M. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumor markers in human leukemias. Anticancer Res. 14:1994;747-751.
3. Crook M. The determination of plasma or serum sialic acid. Clin Biochem. 26:1993;31-38.
4. Patel P.S., Baxi B.R., Adhvaryu S.G., Balar D.B. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma. Anticancer Res. 10:1990;1071-1074.
5. Dnistrian A.M., Schwartz M.K., Katopodis N., Fracchia A.A., Stock C.C. Serum lipid-bound sialic acid as a marker in breast cancer. Cancer. 50:1982;1815-1819.
6. Shamberger R.J. Serum sialic acid in normals and in cancer patients. J Clin Chem Clin Biochem. 22:1984;647-651.
7. Dwivedi C., Dixit M., Hardy R.E. Plasma lipid-bound sialic acid alterations in neoplastic diseases. Experientia. 46:1990;91-94.
8. Patel P.S., Raval G.N., Rawal R.M., Patel G.H., Balar D.B., Shah P.M., Patel D.D. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer. Neoplasma. 42:1995;271-274.
9. Rokicki M., Rokicki W., Czyżewski K., Wojcieszek E. Assessment of the usefulness of estimation of sialic acid contents in the blood serum, pulmonary homogenates and urine of patients with lung cancer. Nowotwory. 37:1987;226-231.
10. Tautu C., Pee D., Dunsmore M., Prorok J.J., Alhadeff J.A. Evaluation of serum sialic acid and carcinoembryonic antigen for the detection of early-stage colorectal cancer. J Clin Lab Anal. 5:1991;247-254.
11. Shimizu Y., Hasumi K., Masubuchi K., Okudaira Y. Management of patients with gynecologic cancer by serum sialic acid determination. Gynecol Oncol. 33:1989;231-236.
12. Vivas I., Spagnuolo L., Palacios P. Total and lipid-bound serum sialic acid as markers for carcinoma of the uterine cervix. Gynecol Oncol. 46:1992;157-162.
13. Plucinsky M.C., Riley W.M., Prorok J.J., Alhadeff J.A. Total and lipid- associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement. Cancer. 58:1986;2680-2685.
14. Patel P.S., Rawal G.N., Balar D.B. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients. Gynecol Oncol. 50:1993;294-299.
15. Crook M. Sialic acid: its importance to platelet function in health and disease. Platelets. 2:1991;1-10.
16. Schwartz P.E., Chambers S.K., Chambers J.T., Gutmann J., Katopodis N., Foemmel R. Circulating tumor markers in the monitoring of gynecologic malignancies. Cancer. 60:1987;353-361.
17. FIGO stages - 1988 revision. Gynecol Oncol 1989;35:125-7.
18. Crook M., Haq M., Tutt P. Evaluation of three assays for the determination of serum total sialic acid. Clin Biochem. 26:1993;449-454.
19. Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem. 234:1959;1971-1975.
20. Gornall A.G., Bardawill C.J., David M.M. Determination of serum proteins by means of the biuret reaction. J Biol Chem. 177:1949;751-766.
21. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J Biol Chem. 193:1951;265-275.
22. Schutter E.M.J., Visser J.J., van Kamp G.J., Mensdorff-Pouilly S., van Dijk W., Hilgers J., Kenemans P. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. Tumor Biol. 13:1992;121-132.
23. Waters P.J., Lewry E., Pennock C.A. Measurement of sialic acid in serum and urine: clinical applications and limitations. Ann Clin Biochem. 29:1992;625-637.
24. Lagana A., Martinez B.P., Marino A., Fago G., Bizzarri M. Correlation of serum sialic acid fractions as markers for carcinoma of the uterine cervix. Anticancer Res. 15:1995;2341-2346.
25. Wong Y.F., Neale E., Felix W.W.S. Serum lipid-associated sialic acid levels in gynecologic malignancies. Int J Gynecol Cancer. 3:1993;143-146.
26. Tseng P.C., Sprance H.E., Carcangiu M.L., Chambers J.T., Schwartz P.E. CA 125, Nb/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma. Obstet Gynecol. 74:1989;384-387.
27. Stefanelli N., Klotz H., Engel A., Bauer P. Serum sialic acid in maligant tumors, bacterial infections, and chronic liver diseases. J Cancer Res Clin Oncol. 109:1985;55-59.
28. Mabry E.W., Carubelli R. Sialic acid in human cancer. Experientia. 28:1972;182-183.
29. Khadapkar S.V., Sheth N.A., Bhide S.V. Independence of sialic acid levels in normal and malignant growth. Cancer Res. 35:1975;1520-1523.
30. Suer S., Sonmez H., Karaaslan I., Baloglu H., Kokoglu E. Tissue sialic acid and fibronectin levels in human prostatic cancer. Cancer Lett. 99:1996;135-137.
31. Maity P. Sialic acid in cervical carcinoma patients. Eur J Gynaecol Oncol. 8:1987;102-104.
32. Vitaioli L., Baldoni E., Indraccolo S.R., Anduzzi D., Ricci R. Evaluation of sialic acid and alpha-neuraminidase activity in normal and pathological endometrium. J Obstet Gynecol. 16:1996;265-268.